{"disease":{"id":"ccus-clonal-cytopenia-of-undetermined-significance","name":"ccus clonal cytopenia of undetermined significance"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06240754","title":"Enasidenib for Patients With Clonal Cytopenia of Undetermined Significance and Mutations in IDH2A Decentralized Trial","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":15,"lead_sponsor_name":"Washington University School of Medicine","has_results":false},{"nct_id":"NCT05102370","title":"A Study of Enasidenib in People With Clonal Cytopenia of Undetermined Significance","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":4,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}